{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:14:36Z","timestamp":1790630076671,"version":"4.1.0"},"reference-count":66,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tzu Chi Med J"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/tcmj.tcmj_103_19","type":"journal-article","created":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T07:31:50Z","timestamp":1572507110000},"page":"137","source":"Crossref","is-referenced-by-count":12,"title":["Clinical characteristics and epilepsy in genomic imprinting disorders: Angelman syndrome and Prader\u2013Willi syndrome"],"prefix":"10.4103","volume":"32","author":[{"given":"Shi-Bing","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzong-Shi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hsin","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ping","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1016-3190.270166-1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/1096-8628(200022)97:2<136::AID-AJMG5>3.0.CO;2-V","article-title":"Prader-Willi and Angelman syndromes: Sister imprinted disorders","author":"Cassidy","year":"2000","journal-title":"Am J Med Genet"},{"key":"key-10.4103\/1016-3190.270166-2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/gim.0b013e31822bead0","article-title":"Prader-Willi syndrome","author":"Cassidy","year":"2012","journal-title":"Genet Med"},{"key":"key-10.4103\/1016-3190.270166-3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1824-7288-36-31","article-title":"Epilepsy in patients with Angelman syndrome","author":"Fiumara","year":"2010","journal-title":"Ital J Pediatr"},{"key":"key-10.4103\/1016-3190.270166-4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s00415-014-7542-1","article-title":"Long-term outcome of epilepsy in patients with Prader-Willi syndrome","author":"Verrotti","year":"2015","journal-title":"J Neurol"},{"key":"key-10.4103\/1016-3190.270166-5","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/dmcn.12182","article-title":"Epilepsy in Prader-Willi syndrome: Experience of a national referral centre","author":"Gilboa","year":"2013","journal-title":"Dev Med Child Neurol"},{"key":"key-10.4103\/1016-3190.270166-6","doi-asserted-by":"crossref","first-page":"e0190849","DOI":"10.1371\/journal.pone.0190849","article-title":"AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial","author":"Allas","year":"2018","journal-title":"PLoS One"},{"key":"key-10.4103\/1016-3190.270166-7","doi-asserted-by":"crossref","unstructured":"Tauber M, Boulanouar K, Diene G, \u00c7abal-Berthoumieu S, Ehlinger V, Fichaux-Bourin P,et al. The use of oxytocin to improve feeding and social skills in infants with Prader-Willi syndrome. Pediatrics 2017;139. pii: e20162976.","DOI":"10.1542\/peds.2016-2976"},{"key":"key-10.4103\/1016-3190.270166-8","first-page":"P3","article-title":"STARS: STARS: A Phase 2 Adult Angelman Syndrome Clinical Trial: Randomized, Double-blind, Safety and Efficacy Study of Gaboxadol (P3.302)","author":"Ochoa-Lubinoff","year":"2018","journal-title":"Neurology"},{"key":"key-10.4103\/1016-3190.270166-9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/ng0997-12","article-title":"Imprinting of the angelman syndrome gene, UBE3A, is restricted to brain","author":"Vu","year":"1997","journal-title":"Nat Genet"},{"key":"key-10.4103\/1016-3190.270166-10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ng0197-74","article-title":"De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome","author":"Matsuura","year":"1997","journal-title":"Nat Genet"},{"key":"key-10.4103\/1016-3190.270166-11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng0197-70","article-title":"UBE3A\/E6-AP mutations cause Angelman syndrome","author":"Kishino","year":"1997","journal-title":"Nat Genet"},{"key":"key-10.4103\/1016-3190.270166-12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ajmg.a.33775","article-title":"Angelman syndrome: Mutations influence features in early childhood","author":"Tan","year":"2011","journal-title":"Am J Med Genet A"},{"key":"key-10.4103\/1016-3190.270166-13","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ajmg.1320370233","article-title":"Parental origin of del (15)(q11-q13) in Angelman and Prader-Willi syndromes","author":"Zori","year":"1990","journal-title":"Am J Med Genet"},{"key":"key-10.4103\/1016-3190.270166-14","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/ajmg.c.30278","article-title":"The behavioral phenotype of the Angelman syndrome","author":"Williams","year":"2010","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"key-10.4103\/1016-3190.270166-15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/ajmg.a.36864","article-title":"Angelman syndrome in adulthood","author":"Larson","year":"2015","journal-title":"Am J Med Genet A"},{"key":"key-10.4103\/1016-3190.270166-16","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrneurol.2016.133","article-title":"Angelman syndrome \u2013 Insights into a rare neurogenetic disorder","author":"Buiting","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"key-10.4103\/1016-3190.270166-17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ejhg.2008.165","article-title":"Prader-Willi syndrome","author":"Cassidy","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"key-10.4103\/1016-3190.270166-18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.yapd.2016.04.005","article-title":"Prader Willi syndrome: Genetics, metabolomics, hormonal function, and new approaches to therapy","author":"Irizarry","year":"2016","journal-title":"Adv Pediatr"},{"key":"key-10.4103\/1016-3190.270166-19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00041444-200512000-00006","article-title":"Autism spectrum disorders in Prader-Willi and Angelman syndromes: A systematic review","author":"Veltman","year":"2005","journal-title":"Psychiatr Genet"},{"key":"key-10.4103\/1016-3190.270166-20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13023-016-0504-1","article-title":"Prader-Willi syndrome mental health research strategy workshop proceedings: The state of the science and future directions","author":"Schwartz","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"key-10.4103\/1016-3190.270166-21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1866-1955-5-18","article-title":"Behavioral profile of adults with Prader-Willi syndrome: Correlations with individual and environmental variables","author":"Jauregi","year":"2013","journal-title":"J Neurodev Disord"},{"key":"key-10.4103\/1016-3190.270166-22","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ridd.2010.12.014","article-title":"Behavioral phenotype in adults with Prader-Willi syndrome","author":"Sinnema","year":"2011","journal-title":"Res Dev Disabil"},{"key":"key-10.4103\/1016-3190.270166-23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.braindev.2007.01.005","article-title":"Behavioral and psychiatric disorders in Prader-Willi syndrome: A population study in Japan","author":"Hiraiwa","year":"2007","journal-title":"Brain Dev"},{"key":"key-10.4103\/1016-3190.270166-24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1017\/S001216220100202X","article-title":"Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: A population-based study","author":"Butler","year":"2002","journal-title":"Dev Med Child Neurol"},{"key":"key-10.4103\/1016-3190.270166-25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41576-018-0092-0","article-title":"Genomic imprinting disorders: Lessons on how genome, epigenome and environment interact","author":"Monk","year":"2019","journal-title":"Nat Rev Genet"},{"key":"key-10.4103\/1016-3190.270166-26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrg3766","article-title":"The role of genomic imprinting in biology and disease: An expanding view","author":"Peters","year":"2014","journal-title":"Nat Rev Genet"},{"key":"key-10.4103\/1016-3190.270166-27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/path.4326","article-title":"In brief: Genomic imprinting and imprinting diseases","author":"Horsthemke","year":"2014","journal-title":"J Pathol"},{"key":"key-10.4103\/1016-3190.270166-28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/342281a0","article-title":"Genetic imprinting suggested by maternal heterodisomy in nondeletion Prader-Willi syndrome","author":"Nicholls","year":"1989","journal-title":"Nature"},{"key":"key-10.4103\/1016-3190.270166-29","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1093\/hmg\/dds130","article-title":"Ube3a-ATS is an atypical RNA polymerase II transcript that represses the paternal expression of Ube3a","author":"Meng","year":"2012","journal-title":"Hum Mol Genet"},{"key":"key-10.4103\/1016-3190.270166-30","first-page":"553","article-title":"SNURF-SNRPN and UBE3A transcript levels in patients with Angelman syndrome","author":"Runte","year":"2004","journal-title":"Hum Genet"},{"key":"key-10.4103\/1016-3190.270166-31","doi-asserted-by":"crossref","unstructured":"Ehrhart F, Janssen KJ, Coort SL, Evelo CT, Curfs LM. Prader-Willi syndrome and Angelman syndrome: Visualisation of the molecular pathways for two chromosomal disorders. World J Biol Psychiatry 2018;1-13.","DOI":"10.1080\/15622975.2018.1439594"},{"key":"key-10.4103\/1016-3190.270166-32","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1523\/JNEUROSCI.4334-07.2008","article-title":"Necdin plays a role in the serotonergic modulation of the mouse respiratory network: Implication for Prader-Willi syndrome","author":"Zanella","year":"2008","journal-title":"J Neurosci"},{"key":"key-10.4103\/1016-3190.270166-33","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1523\/JNEUROSCI.1262-06.2006","article-title":"Necdin promotes GABAergic neuron differentiation in cooperation with dlx homeodomain proteins","author":"Kuwajima","year":"2006","journal-title":"J Neurosci"},{"key":"key-10.4103\/1016-3190.270166-34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.yfrne.2013.01.002","article-title":"Mouse models of Prader-Willi syndrome: A systematic review","author":"Bervini","year":"2013","journal-title":"Front Neuroendocrinol"},{"key":"key-10.4103\/1016-3190.270166-35","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1442-200X.2007.02368.x","article-title":"Prader-Willi syndrome in Taiwan","author":"Lin","year":"2007","journal-title":"Pediatr Int"},{"key":"key-10.4103\/1016-3190.270166-36","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/BF00210291","article-title":"Genotype-phenotype correlation in a series of 167 deletion and non-deletion patients with Prader-Willi syndrome","author":"Gillessen-Kaesbach","year":"1995","journal-title":"Hum Genet"},{"key":"key-10.4103\/1016-3190.270166-37","doi-asserted-by":"crossref","first-page":"e72640","DOI":"10.1371\/journal.pone.0072640","article-title":"Psychiatric illness and intellectual disability in the Prader-Willi syndrome with different molecular defects \u2013 A meta analysis","author":"Yang","year":"2013","journal-title":"PLoS One"},{"key":"key-10.4103\/1016-3190.270166-38","doi-asserted-by":"crossref","unstructured":"Buiting K, Clayton-Smith J, Driscoll DJ, Gillessen-Kaesbach G, Kanber D, Schwinger E, et al. Clinical utility gene card for: Angelman Syndrome. Eur J Hum Genet 2015;23.","DOI":"10.1038\/ejhg.2014.93"},{"key":"key-10.4103\/1016-3190.270166-39","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.yebeh.2016.04.030","article-title":"Seizure treatment in Angelman syndrome: A case series from the Angelman syndrome clinic at massachusetts general hospital","author":"Shaaya","year":"2016","journal-title":"Epilepsy Behav"},{"key":"key-10.4103\/1016-3190.270166-40","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1111\/j.1528-1167.2009.02108.x","article-title":"Epilepsy in Angelman syndrome: A questionnaire-based assessment of the natural history and current treatment options","author":"Thibert","year":"2009","journal-title":"Epilepsia"},{"key":"key-10.4103\/1016-3190.270166-41","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1001\/archneur.63.1.122","article-title":"Epilepsy in patients with Angelman syndrome caused by deletion of the chromosome 15q11-13","author":"Valente","year":"2006","journal-title":"Arch Neurol"},{"key":"key-10.4103\/1016-3190.270166-42","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.braindev.2004.01.009","article-title":"Evolution of seizures and electroencephalographical findings in 23 cases of deletion type Angelman syndrome","author":"Uemura","year":"2005","journal-title":"Brain Dev"},{"key":"key-10.4103\/1016-3190.270166-43","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.yebeh.2017.07.041","article-title":"Epilepsy and sleep disorders improve in adolescents and adults with Angelman syndrome: A multicenter study on 46 patients","author":"Sueri","year":"2017","journal-title":"Epilepsy Behav"},{"key":"key-10.4103\/1016-3190.270166-44","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.braindev.2003.11.009","article-title":"Electroclinical characteristics of seizures-comparing Prader-willi syndrome with Angelman syndrome","author":"Wang","year":"2005","journal-title":"Brain Dev"},{"key":"key-10.4103\/1016-3190.270166-45","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/adc.79.5.423","article-title":"Parental view of epilepsy in Angelman syndrome: A questionnaire study","author":"Ruggieri","year":"1998","journal-title":"Arch Dis Child"},{"key":"key-10.4103\/1016-3190.270166-46","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/ana.410430412","article-title":"Angelman syndrome: Correlations between epilepsy phenotypes and genotypes","author":"Minassian","year":"1998","journal-title":"Ann Neurol"},{"key":"key-10.4103\/1016-3190.270166-47","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1002\/ajmg.a.36015","article-title":"Evaluating the frequency and characteristics of seizures in 142 Japanese patients with Prader-Willi syndrome","author":"Takeshita","year":"2013","journal-title":"Am J Med Genet A"},{"key":"key-10.4103\/1016-3190.270166-48","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.yebeh.2010.07.007","article-title":"Epilepsy in Prader-Willi syndrome: Clinical characteristics and correlation to genotype","author":"Vendrame","year":"2010","journal-title":"Epilepsy Behav"},{"key":"key-10.4103\/1016-3190.270166-49","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/ajmg.a.32934","article-title":"Characteristics and frequency of seizure disorder in 56 patients with Prader-Willi syndrome","author":"Fan","year":"2009","journal-title":"Am J Med Genet A"},{"key":"key-10.4103\/1016-3190.270166-50","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuron.2016.02.040","article-title":"GABAergic neuron-specific loss of ube3a causes Angelman syndrome-like EEG abnormalities and enhances seizure susceptibility","author":"Judson","year":"2016","journal-title":"Neuron"},{"key":"key-10.4103\/1016-3190.270166-51","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/BF00441976","article-title":"The EEG in early diagnosis of the Angelman (happy puppet) syndrome","author":"Boyd","year":"1988","journal-title":"Eur J Pediatr"},{"key":"key-10.4103\/1016-3190.270166-52","first-page":"701","article-title":"Revisiting epilepsy and the electroencephalogram patterns in Angelman syndrome","author":"Leyser","year":"2014","journal-title":"Neurol Sci"},{"key":"key-10.4103\/1016-3190.270166-53","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1528-1157.1997.tb01097.x","article-title":"Evolution of epilepsy and EEG findings in Angelman syndrome","author":"Laan","year":"1997","journal-title":"Epilepsia"},{"key":"key-10.4103\/1016-3190.270166-54","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.braindev.2012.04.006","article-title":"Implications of slow waves and shifting epileptiform discharges in Angelman syndrome","author":"Yum","year":"2013","journal-title":"Brain Dev"},{"key":"key-10.4103\/1016-3190.270166-55","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.seizure.2007.08.004","article-title":"Epilepsy in Angelman syndrome","author":"Pelc","year":"2008","journal-title":"Seizure"},{"key":"key-10.4103\/1016-3190.270166-56","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1046\/j.1528-1157.2003.66502.x","article-title":"Angelman syndrome: Difficulties in EEG pattern recognition and possible misinterpretations","author":"Valente","year":"2003","journal-title":"Epilepsia"},{"key":"key-10.4103\/1016-3190.270166-57","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1212\/WNL.54.5.1185","article-title":"Topiramate therapy of epilepsy associated with Angelman's syndrome","author":"Franz","year":"2000","journal-title":"Neurology"},{"key":"key-10.4103\/1016-3190.270166-58","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/ajmg.a.38457","article-title":"A randomized controlled trial of levodopa in patients with Angelman syndrome","author":"Tan","year":"2018","journal-title":"Am J Med Genet A"},{"key":"key-10.4103\/1016-3190.270166-59","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13023-018-0891-6","article-title":"A randomized placebo controlled clinical trial to evaluate the efficacy and safety of minocycline in patients with Angelman syndrome (A-MANECE study)","author":"Ruiz-Antoran","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"key-10.4103\/1016-3190.270166-60","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nature13975","article-title":"Towards a therapy for Angelman syndrome by targeting a long non-coding RNA","author":"Meng","year":"2015","journal-title":"Nature"},{"key":"key-10.4103\/1016-3190.270166-61","first-page":"185","article-title":"Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons","author":"Huang","year":"2011","journal-title":"Nature"},{"key":"key-10.4103\/1016-3190.270166-62","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/ijpo.12131","article-title":"Effects of exenatide on weight and appetite in overweight adolescents and young adults with Prader-Willi syndrome","author":"Salehi","year":"2017","journal-title":"Pediatr Obes"},{"key":"key-10.4103\/1016-3190.270166-63","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1111\/dom.13021","article-title":"Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome: A randomized, double-blind, placebo-controlled trial","author":"McCandless","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"key-10.4103\/1016-3190.270166-64","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1093\/hmg\/ddq424","article-title":"A single postnatal injection of oxytocin rescues the lethal feeding behaviour in mouse newborns deficient for the imprinted Magel2 gene","author":"Schaller","year":"2010","journal-title":"Hum Mol Genet"},{"key":"key-10.4103\/1016-3190.270166-65","first-page":"573","article-title":"Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: A study of five cases","author":"Swaab","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/1016-3190.270166-66","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/ajmg.a.38160","article-title":"Oxytocin treatment in children with Prader-Willi syndrome: A double-blind, placebo-controlled, crossover study","author":"Miller","year":"2017","journal-title":"Am J Med Genet A"}],"container-title":["Tzu Chi Medical Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:36:40Z","timestamp":1786732600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tcmj.tcmj_103_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"alternative-id":["270166"],"URL":"https:\/\/doi.org\/10.4103\/tcmj.tcmj_103_19","relation":{},"ISSN":["1016-3190"],"issn-type":[{"value":"1016-3190","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}